On the filings, MetLife (MET) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.
Cash-generative, diversified life insurer with strong capital return — but GAAP earnings are sliding and the 18x multiple is full.
Cheap, ~5%-yielding life insurer recovering off 2022 losses — but lumpy, rate-sensitive earnings keep it a hold, not a chase.
| Metric | MET | PRU |
|---|---|---|
| Fundamentals score | 71 | 66 |
| Revenue growth (YoY) | +8.5% | -13.7% |
| Net income growth (YoY) | -23.7% | +31.1% |
| Net margin | 138.7% | 5.9% |
| Return on equity | 11.9% | 11.0% |
| ROIC (est.) | 9.2% | — |
| Liabilities / Equity | 25.22 | 22.76 |
| Piotroski F-score | 5 / 9 | 6 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 8:08 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 19, 2026, 8:17 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.